Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India To Raise Drug-Access Issue In Bilateral Talks With Japan

This article was originally published in PharmAsia News

Executive Summary

The Indian government plans to raise ease-of-access issues with its Japanese counterpart on behalf of India's pharmaceutical industry. Indian pharmas have complained that Japanese are hesitant to sell Indian drugs, leaving the companies to circumvent the blockage by hiring Chinese or South Korean agents in Japan. The two nations have scheduled a meeting to discuss a comprehensive economic partnership agreement between the two countries. The head of the Indian Drug Manufacturers' Association, Ashok Kumar, said Japan also has different specifications for drugs, causing a translation problem that leads to rejections. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC070854

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel